Skip to content

Examination concerning utility of relapse prevention of factor and ursodeoxycholic acid related to relapse after total biliary stone is removed

Examination concerning utility of relapse prevention of factor and ursodeoxycholic acid related to relapse after total biliary stone is removed - Examination concerning utility of relapse prevention of factor and ursodeoxycholic acid related to relapse after total biliary stone is removed

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000003732
Enrollment
360
Registered
2010-06-10
Start date
2010-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After removing a total biliary stone

Interventions

Person who takes medicine every day Person who doesn&#39
t take medicine

Sponsors

Hiroshima University hospital Department of General Internal Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient of enforcement of total biliary stone removal art of treatment first time 1.The age:The age when agreement is acquired is full 20 years old or more. 2.Patient to whom all gallstone in the common bile ducts are removed by passing nipple endoscope treatment 3.Male and Female 4.Patient who obtained agreement of this research participation by document

Exclusion criteria

Exclusion criteria: 1.Patient who has received treatment of gastrectomy 2.Patient who has received treatment by malignant tumor 3.Patient whom biliary tract completely blockaded 4.Patient who has received treatment due to fulminant hepatitis 5.Patient who is scheduling patient and pregnancy with symptom of pregnancy while suckling while getting pregnant 6.Patient of alcoholism 7.Patient who has the past of hypersensitivity for experimental drug 8.Patient who has received treatment with medicine made of bile acid ([uruso]and[chinokapuseru],etc.), bile acid absorbents([korebain]and quest orchis),profit pluck medicines(dehydrocholic acid note, spa curl,[ferubiden],and[inchinkoutou],etc.),and medicines under development 9.Additionally, patient whom research responsibility doctor etc.judged to be suitable case as target in present study

Design outcomes

Primary

MeasureTime frame
Patient of enforcement of total biliary stone removal art of treatment first time Comparison research between going side by side groups(Randomizing allocation opening examination) Research medicine administering group,Passage observation group

Secondary

MeasureTime frame
It random allocation = allocates it according to the layer. Example of removing gallbladder, example of having stone having gallbladder, and example of no stone having gallbladder

Countries

Japan

Contacts

Public ContactTazuma Susumu

Hiroshima University hospital Department of General Internal Medicine

stazuma@hiroshima-u.ac.jp082-257-5461

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026